LSI vs MCRB
LSI (LSI) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
LSI (LSI) common stock.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
LSI does not have a complete income-statement cache yet.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
MCRB currently screens at market cap $109.8M.
Not investment advice. Open the LSI and MCRB stock pages for the full models.
Not investment advice.